Maximize the Impact of Your Metabolomics Data:

Drive Cutting Edge  Metabolism Research

We enable metabolism research from bench to population-scale to unravel patient phenotypes and cellular physiology with unprecedented detail.

General Metabolics’ proprietary technology platform for metabolomics is uniquely suited for analyzing large-scale biological and clinical data sets.

one_partner

One Partner, Multiple Tools

Applying the right tool from exploratory to focused inquiry.

comparative-analysis

Interactive Data Analysis

Including differential analysis, pathway enrichment etc,.

multi-omics3

Integrated multi-omics

Enabling systems-level insight, and new links to genomic features.

high-throughput

Ultra-high throughput

Providing acquisition of up to 1,000 metabolite profiles in a single day.

data-generation

Automated Data Pipelines

Creating Bio/Pharma informatics for any researcher.

rapid-turnaround-icon

Rapid Turnaround

Delivering data & interpretation in less than two weeks.

We collaborate with industrial and academic researchers to deliver ultra high-throughput metabolite analysis with unprecedented speed and unlimited scale.

GMet enables metabolomics to function at the speed and scale of the other tools of life science. High throughput data acquisition and automated data processing are coupled to an integrated software ecosystem to rapidly deliver biological analysis and insight. Our suite of capabilities include untargeted metabolomics, focused inquiry with LCMS/MS, lipidomics, network-based integrated-omics, as well as interactive data analysis tools.  Automated data pipelines and informatics support rapid time to insight at any experimental scale with data delivery in less than 2 weeks.

At General Metabolics we provide a full suite of metabolomics capabilities that enable you to make metabolomics a central part of ongoing research, including untargeted metabolomics, focused inquiry with LCMS/MS, lipidomics, isotopic label tracing, network-based integrated-omics, as well as interactive data analysis tools.  These tools have helped our clients accelerate therapeutics development, pathway engineering, biomarker discovery and mechanistic cellular research.

We handle studies from bench to population scale.

Management Team

Edward Driggers, PhD - Founder and President

Previously at Agios, Ensemble, and Ironwood Pharma

Scientific Advisors

Uwe Sauer, PhD

Co-Founder Professor at ETH Zurich

Nicola Zamboni, PhD

Co-Founder Professor at ETH Zurich

Ralph DeBerardinis, MD, PhD

Professor at UT Southwestern and HHMI